Assessment of Artificial Intelligence for Treatment Decision Recommendation of Adult Skeletal Class III Patients
NCT ID: NCT06002373
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2023-05-01
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This diagnostic test accuracy study involves collecting a diverse dataset of adult patients diagnosed with skeletal Class III malocclusion. AI algorithms will be trained on this dataset using various clinical and radiographic parameters to learn patterns and make treatment recommendations. The study will then compare the AI-generated treatment recommendations to those provided by experienced orthodontists.
Key aspects of the study include:
AI Reliability: The primary objective is to assess how consistently and accurately the AI system can recommend appropriate treatment decisions for adult skeletal Class III patients.
Diagnostic Test Accuracy: The study will determine the sensitivity, specificity, positive predictive value, and negative predictive value of the AI-generated treatment recommendations. This analysis will highlight the AI's ability to correctly identify patients who require specific treatment interventions.
Clinical Validity: Researchers will investigate whether the AI recommendations align with the decisions made by experienced orthodontists. This assessment is crucial to establish the AI system's clinical applicability.
Potential Benefits: If the AI system proves reliable and accurate, it could offer a time-efficient and standardized method for treatment decision support, aiding orthodontists in providing personalized care to adult skeletal Class III patients.
By conducting this study, researchers aim to contribute to the advancement of AI-assisted medical decision-making within the field of orthodontics. Successful outcomes would have the potential to revolutionize treatment planning processes, improve patient outcomes, and provide a valuable tool for orthodontists to make informed treatment decisions for adult skeletal Class III patients
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Diagnostic Accuracy of Artificial Intelligence in Treatment Planning for Non-growing Class II Cases
NCT06792747
Reliability of Artificial Intelligence for Treatment Decision for Adult Skeletal Open Bite Patients
NCT06992908
Validation of AI-Based Cephalometric Analysis in Orthodontics
NCT07315152
AI-Guided Treatment Planning in Orthodontic Patients With Missing Upper Lateral Incisors
NCT07133867
Evaluation of Artificial Intelligence Models for Diagnosis of Anterior Open Bite Malocclusion
NCT06140849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Skeletal class III patients
* No congenital deformity, syndrome, or cleft.
* No previous surgical intervention
* No mandibular transverse functional shift.
* Normal overjet, overbite after completion of treatment.
* Patients with well finished occlusion.
* Patients who have achieved adequate functional and aesthetic results at the end of their treatment.
* Good quality initial and final lateral cephalometric radiographs.
* No sex predilection.
Exclusion Criteria
* Patients with pseudo class III.
* Syndromic patients.
* Patients with facial deformity at the naso-maxillary complex
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maha Abd El-Monem Nasr
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Abd El Rahim
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.